Revenue
103 thousand USD
1996-03-31 · USD
Exact inputs and evidence
- Revenue: 103000 USD Source
Fundies. English
ENDOVASCULAR TECHNOLOGIES INC
EDGAR9 filing records in this dataset, filed from 1996-05-14 to 1997-11-12. Explore the available filing history and original sources.
Latest quarter
Operating margin
-2,819.67%
1996-03-31 · %
Operating cash flow
-2.4 million USD
1996-03-31 · USD
Exact inputs and evidence
- Operating Cash Flow: -2397045 USD Source
Free cash flow
-2.74 million USD
1996-03-31 · USD
- Cash and cash equivalents
- 4.54 million USD Source
Exact value
4536962 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 1997-11-12.
Financial data available through: 1996-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 3 of 11 periods available· newest 1996-12-31
- Net income: 3 of 11 periods available· newest 1996-12-31
- Operating cash flow: 3 of 11 periods available· newest 1996-12-31
- Capital expenditure: 3 of 11 periods available· newest 1996-12-31
- Total assets: 2 of 11 periods available· newest 1996-12-31
- liabilities: No compatible figures in this window
- Current assets: 2 of 11 periods available· newest 1996-12-31
- Current liabilities: 2 of 11 periods available· newest 1996-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 1996-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 5.28 millionPrior period
−USD 8.26 million
–
Current period
−USD 13.54 million
–
Exact inputs and evidence
-13537385 − -8262160 = -5275225 USD
-8262160 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source-13537385 USD · 1996-01-01 – 1996-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.29 millionPrior period
−USD 7.41 million
–
Current period
−USD 12.7 million
–
Exact inputs and evidence
-12704606 − -7411041 = -5293565 USD
-7411041 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source-12704606 USD · 1996-01-01 – 1996-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+545.5%Prior period
USD 231,288
–
Current period
USD 1.49 million
–
Exact inputs and evidence
1492905 − 231288 = 1261617 USD
231288 USD · 1995-01-01 – 1995-12-31
Inspect prior input Prior source1492905 USD · 1996-01-01 – 1996-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 1994 1994-01-01 – 1994-12-31 | −USD 7.88 million Exact valueExact value: -7879451 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.3 million Exact valueExact value: -7302700 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 662,049 Exact valueExact value: 662049 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.96 million Calculation and evidence-7302700 − 662049 USD Exact free cash flow: -7964749 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 1995 1995-01-01 – 1995-12-31 | −USD 8.26 million Exact valueExact value: -8262160 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.41 million Exact valueExact value: -7411041 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 231,288 Exact valueExact value: 231288 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.64 million Calculation and evidence-7411041 − 231288 USD Exact free cash flow: -7642329 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 1996 1996-01-01 – 1996-12-31 | −USD 13.54 million Exact valueExact value: -13537385 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.7 million Exact valueExact value: -12704606 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.49 million Exact valueExact value: 1492905 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.2 million Calculation and evidence-12704606 − 1492905 USD Exact free cash flow: -14197511 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
9 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001005122, 1005122, edgar:1005122